This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Christoph Kreer, Ph.D
Senior Scientist at University of Cologne
Speaker

Profile

Dr. Christoph Kreer is a senior scientist at the Institute of Virology, University of Cologne, Germany, where he leads a research unit on immunodynamics and molecular evolution. His work focuses on how immune history and antigen evolution shape human B-cell responses across infections and cancer. Using single B cell technologies, molecular evolution, and systems-level repertoire analysis, he isolates and characterizes human antibodies against emerging viral threats, including influenza A and zoonotic variants. His research aims to uncover principles that enable the rational steering of immune responses for therapeutic and preventive applications.

Agenda Sessions

  • Isolation and Characterization of Human Antibodies Against Influenza A Viruses

    14:25